Published online by Cambridge University Press: 29 January 2018
Since 1932 the amylobarbitone (amobarbital sodium, Amytal) interview has been used as a technique for diagnostic evaluation of patients with psychiatric illnesses (Lindemann, 1932). Amytal has also been used to make mute patients talk, as a sedative, a mood elevator, and as an agent in various other types of psychiatric treatment such as sleep therapy, abreaction, narcoanalysis (Horsley, 1936), narcosynthesis (Grinker et al., 1945), narcosuggestion, and narcoplexis (Brickner et al., 1950).
eLetters
No eLetters have been published for this article.